Both in Pharmaceuticals
Immuneering vs CAMP4 Therapeutics
Over the past year IMRX returned −42.2% and CAMP returned −3.3%; their daily moves had a correlation of 0.11.
IMRX −42.2% CAMP −3.3%Growth of $1, one year, split-adjusted
| Metric | IMRX | CAMP |
|---|---|---|
| Price | $3.79 | $3.81 |
| Market cap | $245.5M | $239.1M |
| Today | +2.99% | −0.52% |
| 1 month | −1.0% | −3.8% |
| 6 months | −27.0% | −6.2% |
| Year to date | −42.4% | −37.8% |
| 1 year | −42.2% | −3.3% |
| Revenue growth (YoY) | — | +18.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1884.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 56.7× |
| Net cash | $145.4M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 52.7% | 83.8% |
| Short % of float | 29.2% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).